Logo image of JBLU

JETBLUE AIRWAYS CORP (JBLU) Stock Fundamental Analysis

NASDAQ:JBLU - Nasdaq - US4771431016 - Common Stock - Currency: USD

7.01  -0.23 (-3.18%)

After market: 7.04 +0.03 (+0.43%)

Fundamental Rating

2

Taking everything into account, JBLU scores 2 out of 10 in our fundamental rating. JBLU was compared to 23 industry peers in the Passenger Airlines industry. Both the profitability and financial health of JBLU have multiple concerns. JBLU is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year JBLU has reported negative net income.
JBLU had a positive operating cash flow in the past year.
JBLU had negative earnings in each of the past 5 years.
The reported operating cash flow has been mixed in the past 5 years: JBLU reported negative operating cash flow in multiple years.
JBLU Yearly Net Income VS EBIT VS OCF VS FCFJBLU Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B

1.2 Ratios

Looking at the Return On Assets, with a value of -5.14%, JBLU is in line with its industry, outperforming 43.48% of the companies in the same industry.
JBLU has a Return On Equity of -32.30%. This is comparable to the rest of the industry: JBLU outperforms 43.48% of its industry peers.
Industry RankSector Rank
ROA -5.14%
ROE -32.3%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
JBLU Yearly ROA, ROE, ROICJBLU Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20 -20 -30

1.3 Margins

Looking at the Gross Margin, with a value of 64.75%, JBLU is in the better half of the industry, outperforming 78.26% of the companies in the same industry.
JBLU's Gross Margin has been stable in the last couple of years.
JBLU does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 64.75%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.27%
GM growth 5Y-1.02%
JBLU Yearly Profit, Operating, Gross MarginsJBLU Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50

More info and screens

3

2. Health

2.1 Basic Checks

JBLU does not have a ROIC to compare to the WACC, probably because it is not profitable.
There is no outstanding debt for JBLU. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
JBLU Yearly Shares OutstandingJBLU Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 100M 200M 300M
JBLU Yearly Total Debt VS Total AssetsJBLU Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2B 4B 6B 8B 10B

2.2 Solvency

Based on the Altman-Z score of 0.81, we must say that JBLU is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of JBLU (0.81) is comparable to the rest of the industry.
JBLU has a Debt/Equity ratio of 2.98. This is a high value indicating a heavy dependency on external financing.
JBLU has a Debt to Equity ratio (2.98) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 2.98
Debt/FCF N/A
Altman-Z 0.81
ROIC/WACCN/A
WACC6.84%
JBLU Yearly LT Debt VS Equity VS FCFJBLU Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 2B 4B

2.3 Liquidity

A Current Ratio of 1.21 indicates that JBLU should not have too much problems paying its short term obligations.
The Current ratio of JBLU (1.21) is better than 91.30% of its industry peers.
A Quick Ratio of 1.18 indicates that JBLU should not have too much problems paying its short term obligations.
JBLU has a better Quick ratio (1.18) than 91.30% of its industry peers.
Industry RankSector Rank
Current Ratio 1.21
Quick Ratio 1.18
JBLU Yearly Current Assets VS Current LiabilitesJBLU Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 1B 2B 3B

More info and screens

3

3. Growth

3.1 Past

JBLU shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -53.19%.
JBLU shows a decrease in Revenue. In the last year, the revenue decreased by -3.50%.
Measured over the past years, JBLU shows a small growth in Revenue. The Revenue has been growing by 2.77% on average per year.
EPS 1Y (TTM)-53.19%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-10.53%
Revenue 1Y (TTM)-3.5%
Revenue growth 3Y15.41%
Revenue growth 5Y2.77%
Sales Q2Q%-2.06%

3.2 Future

Based on estimates for the next years, JBLU will show a very strong growth in Earnings Per Share. The EPS will grow by 30.57% on average per year.
The Revenue is expected to grow by 5.91% on average over the next years.
EPS Next Y12.84%
EPS Next 2Y32.57%
EPS Next 3Y30.57%
EPS Next 5YN/A
Revenue Next Year5.23%
Revenue Next 2Y2.28%
Revenue Next 3Y5.91%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
JBLU Yearly Revenue VS EstimatesJBLU Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2B 4B 6B 8B 10B
JBLU Yearly EPS VS EstimatesJBLU Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 2 -2 -4

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

JBLU reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year JBLU is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
JBLU Price Earnings VS Forward Price EarningsJBLU Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20

4.2 Price Multiples

JBLU's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. JBLU is cheaper than 69.57% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 10.68
JBLU Per share dataJBLU EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20

4.3 Compensation for Growth

JBLU's earnings are expected to grow with 30.57% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y32.57%
EPS Next 3Y30.57%

More info and screens

0

5. Dividend

5.1 Amount

JBLU does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

JETBLUE AIRWAYS CORP

NASDAQ:JBLU (2/21/2025, 8:00:02 PM)

After market: 7.04 +0.03 (+0.43%)

7.01

-0.23 (-3.18%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupTransportation
GICS IndustryPassenger Airlines
Earnings (Last)01-28 2025-01-28/bmo
Earnings (Next)04-21 2025-04-21/bmo
Inst Owners82.16%
Inst Owner Change10.86%
Ins Owners10.27%
Ins Owner Change5.02%
Market Cap2.43B
Analysts50
Price Target6.76 (-3.57%)
Short Float %17.05%
Short Ratio2.46
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)103.75%
Min EPS beat(2)37.94%
Max EPS beat(2)169.56%
EPS beat(4)4
Avg EPS beat(4)64.76%
Min EPS beat(4)18.47%
Max EPS beat(4)169.56%
EPS beat(8)6
Avg EPS beat(8)28.04%
EPS beat(12)8
Avg EPS beat(12)-6.97%
EPS beat(16)12
Avg EPS beat(16)-0.68%
Revenue beat(2)0
Avg Revenue beat(2)-0.81%
Min Revenue beat(2)-0.88%
Max Revenue beat(2)-0.74%
Revenue beat(4)0
Avg Revenue beat(4)-0.91%
Min Revenue beat(4)-1.78%
Max Revenue beat(4)-0.26%
Revenue beat(8)0
Avg Revenue beat(8)-1.47%
Revenue beat(12)0
Avg Revenue beat(12)-1.65%
Revenue beat(16)4
Avg Revenue beat(16)-0.61%
PT rev (1m)4.52%
PT rev (3m)5.96%
EPS NQ rev (1m)26.65%
EPS NQ rev (3m)21.93%
EPS NY rev (1m)0.83%
EPS NY rev (3m)-4.71%
Revenue NQ rev (1m)0.92%
Revenue NQ rev (3m)0.17%
Revenue NY rev (1m)0.26%
Revenue NY rev (3m)-0.26%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.26
P/FCF N/A
P/OCF 32.42
P/B 0.92
P/tB 1.08
EV/EBITDA 10.68
EPS(TTM)-0.72
EYN/A
EPS(NY)-0.63
Fwd EYN/A
FCF(TTM)-4.5
FCFYN/A
OCF(TTM)0.22
OCFY3.08%
SpS26.89
BVpS7.62
TBVpS6.49
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -5.14%
ROE -32.3%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 64.75%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.27%
GM growth 5Y-1.02%
F-Score4
Asset Turnover0.56
Health
Industry RankSector Rank
Debt/Equity 2.98
Debt/FCF N/A
Debt/EBITDA 15.8
Cap/Depr 253.1%
Cap/Sales 17.53%
Interest Coverage N/A
Cash Conversion 15.06%
Profit Quality N/A
Current Ratio 1.21
Quick Ratio 1.18
Altman-Z 0.81
F-Score4
WACC6.84%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-53.19%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-10.53%
EPS Next Y12.84%
EPS Next 2Y32.57%
EPS Next 3Y30.57%
EPS Next 5YN/A
Revenue 1Y (TTM)-3.5%
Revenue growth 3Y15.41%
Revenue growth 5Y2.77%
Sales Q2Q%-2.06%
Revenue Next Year5.23%
Revenue Next 2Y2.28%
Revenue Next 3Y5.91%
Revenue Next 5YN/A
EBIT growth 1Y-240.95%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year492.11%
EBIT Next 3Y98.74%
EBIT Next 5YN/A
FCF growth 1Y-182.1%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-86.21%
OCF growth 3YN/A
OCF growth 5YN/A